AI helps you reading Science
Synthesis and pharmacological profile of two novel heterocyclic chromanols, CP-80,798 and CP-85,958, as potent LTD4 receptor antagonists
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, no. 13 (1995): 1365-1370
EI
Abstract
The development of two novel LTD(4) receptor antagonists as clinical candidates for the treatment of asthma is described. The first generation compound, CP-80,798, was found to be a balanced 5-lipoxygenase inhibitor (5-LOI)/LTD(4) antagonist (LTD(4)-A), while the second generation compound, CP-85,958, is a selective LTD(4) antagonist.
Code:
Data:
Tags
Comments
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn